Revvity's Q4 Results: Expectations vs Reality
Update: 2026-01-05
Description
Revvity, a Massachusetts-based life sciences and diagnostics company, is set to report its fourth-quarter results. Despite a strong track record of beating Wall Street estimates in the last four quarters, the companys stock has dropped by 12.4% over the past year, underperforming the healthcare sector fund and the S&P 500. Revenue growth has been modest, averaging just 2% over the last two years, and adjusted operating margins have declined by over 9 percentage points in five years due to higher costs. Investors remain cautious ahead of the earnings report, despite the companys history of surprises. Checkout Solipillow.com
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
